← Leaderboards
Carolyn Calfee
University Of California, San Francisco
$18,194,415
Attributed
$18,194,415
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,194,415 · 10
By mechanism
R35$7,914,954 · 2
U54$2,759,955 · 2
R01$2,704,809 · 2
P50$2,695,211 · 1
U01$1,118,088 · 1
K23$760,860 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Pamela May Ling$21,183,506
- Gideon St.helen$5,881,549
- Peyton Jacob$8,022,921
- Benjamin W Chaffee$4,161,847
- Mitchell Cohen$5,892,451
Others in their field
Top investigators on “Syndrome”
- David Heimbrook · Leidos Biomedical Research, Inc.$365,165,418
- George R Seage · Abt Associates, Inc.$241,364,559
- Barbara Driver · Westat, Inc.$177,853,041
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$174,377,607
- Michelle Vargas · Ppd Development Lp$163,846,102
- Judith S. Currier · University Of California Los Angeles$149,333,820
Research focus
SyndromeLungCritical IllnessCohortAcute Respiratory FailureLung InjuryBiological MarkersInflammatoryPredispositionEpithelialCritical CareInjuryPlasmaAdultEnrollmentProspectiveFutureResearch PersonnelMortalityBiologicalCigarette SmokeClinical TrialsBiologyIncidence
Grant awards (35)
Advancing Precision Medicine for ARDS and Sepsis$1,147,992
R35 · FY2025 · HL · contact PI
Molecular Phenotyping of ARDS, Pneumonia, and Sepsis using Latent Class Analysis and Metagenomic Sequencing$599,173
U01 · FY2025 · HL · contact PI
Precision Medicine in the Acute Respiratory Distress Syndrome$948,798
R35 · FY2024 · HL · contact PI
Molecular Phenotyping of ARDS, Pneumonia, and Sepsis using Latent Class Analysis and Metagenomic Sequencing$347,027
U01 · FY2024 · HL · contact PI
Precision Medicine in the Acute Respiratory Distress Syndrome$968,160
R35 · FY2023 · HL · contact PI
Molecular Phenotyping of ARDS, Pneumonia, and Sepsis using Latent Class Analysis and Metagenomic Sequencing$171,888
U01 · FY2023 · HL · contact PI
Precision Medicine in the Acute Respiratory Distress Syndrome$967,250
R35 · FY2022 · HL · contact PI
PROJECT 1: IMPACT OF DIFFERENT E-CIGARETTE CHARACTERISTICS ON ACUTE LUNG INJURY$583,421
U54 · FY2022 · HL · contact PI
Precision Medicine in the Acute Respiratory Distress Syndrome$967,250
R35 · FY2021 · HL · contact PI
PROJECT 1: IMPACT OF DIFFERENT E-CIGARETTE CHARACTERISTICS ON ACUTE LUNG INJURY$595,681
U54 · FY2021 · HL · contact PI
Precision Medicine in the Acute Respiratory Distress Syndrome$965,311
R35 · FY2020 · HL · contact PI
PROJECT 1: IMPACT OF DIFFERENT E-CIGARETTE CHARACTERISTICS ON ACUTE LUNG INJURY$595,324
U54 · FY2020 · HL · contact PI
Precision Medicine in the Acute Respiratory Distress Syndrome$963,597
R35 · FY2019 · HL · contact PI
PROJECT 1: IMPACT OF DIFFERENT E-CIGARETTE CHARACTERISTICS ON ACUTE LUNG INJURY$470,424
U54 · FY2019 · HL · contact PI
Precision Medicine in the Acute Respiratory Distress Syndrome$986,596
R35 · FY2018 · HL · contact PI
PROJECT 1: IMPACT OF DIFFERENT E-CIGARETTE CHARACTERISTICS ON ACUTE LUNG INJURY$515,105
U54 · FY2018 · CA · contact PI
Project 4: Quantification and Biomarkers of Short-Term Pulmonary Effect$635,852
P50 · FY2017 · CA · contact PI
Molecular Endotypes of ARDS: Identification, Biology, and Differential Response to Therapy$400,120
R01 · FY2017 · HL · contact PI
ARDS Endotypes: Expanded Analysis of Clinical and Biological Phenotypes and Evolution Over Time$120,269
K24 · FY2017 · HL · contact PI
Project 4: Quantification and Biomarkers of Short-Term Pulmonary Effect p302-340$429,509
P50 · FY2016 · CA · contact PI
Molecular Endotypes of ARDS: Identification, Biology, and Differential Response to Therapy$406,026
R01 · FY2016 · HL · contact PI
Cigarette Smoke Exposure and Acute Lung Injury After Severe Blunt Trauma$385,974
R01 · FY2016 · HL · contact PI
ARDS Endotypes: Expanded Analysis of Clinical and Biological Phenotypes and Evolution Over Time$120,269
K24 · FY2016 · HL · contact PI
Project 4: Quantification and Biomarkers of Short-Term Pulmonary Effect p302-340$636,571
P50 · FY2015 · CA · contact PI
Cigarette Smoke Exposure and Acute Lung Injury After Severe Blunt Trauma$380,204
R01 · FY2015 · HL · contact PI
Project 4: Quantification and Biomarkers of Short-Term Pulmonary Effect p302-340$553,795
P50 · FY2014 · CA · contact PI
Cigarette Smoke Exposure and Acute Lung Injury After Severe Blunt Trauma$378,525
R01 · FY2014 · HL · contact PI
Project 4: Quantification and Biomarkers of Short-Term Pulmonary Effect p302-340$439,484
P50 · FY2013 · CA · contact PI
Cigarette Smoke Exposure and Acute Lung Injury After Severe Blunt Trauma$367,710
R01 · FY2013 · HL · contact PI
Cigarette Smoke Exposure and Acute Lung Injury After Severe Blunt Trauma$386,250
R01 · FY2012 · HL · contact PI
Impact of Cigarette Smoke Exposure on Acute Lung Injury$152,820
K23 · FY2012 · HL · contact PI
Impact of Cigarette Smoke Exposure on Acute Lung Injury$152,820
K23 · FY2011 · HL · contact PI
Impact of Cigarette Smoke Exposure on Acute Lung Injury$152,820
K23 · FY2010 · HL · contact PI
Impact of Cigarette Smoke Exposure on Acute Lung Injury$151,200
K23 · FY2009 · HL · contact PI
Impact of Cigarette Smoke Exposure on Acute Lung Injury$151,200
K23 · FY2008 · HL · contact PI